These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 18175243)

  • 1. Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age.
    Chaiworapongsa T; Romero R; Gotsch F; Espinoza J; Nien JK; Goncalves L; Edwin S; Kim YM; Erez O; Kusanovic JP; Pineles BL; Papp Z; Hassan S
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):41-52. PubMed ID: 18175243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation.
    Chaiworapongsa T; Espinoza J; Gotsch F; Kim YM; Kim GJ; Goncalves LF; Edwin S; Kusanovic JP; Erez O; Than NG; Hassan SS; Romero R
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):25-40. PubMed ID: 18175242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
    Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.
    Erez O; Romero R; Espinoza J; Fu W; Todem D; Kusanovic JP; Gotsch F; Edwin S; Nien JK; Chaiworapongsa T; Mittal P; Mazaki-Tovi S; Than NG; Gomez R; Hassan SS
    J Matern Fetal Neonatal Med; 2008 May; 21(5):279-87. PubMed ID: 18446652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal death: a condition with a dissociation in the concentrations of soluble vascular endothelial growth factor receptor-2 between the maternal and fetal compartments.
    Chaiworapongsa T; Kusanovic JP; Savasan ZA; Mazaki-Tovi S; Kim SK; Vaisbuch E; Tarca AL; Mittal P; Ogge G; Madan I; Dong Z; Yeo L; Hassan SS; Romero R
    J Matern Fetal Neonatal Med; 2010 Sep; 23(9):960-72. PubMed ID: 20158395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble Tie-2.
    Gotsch F; Romero R; Kusanovic JP; Chaiworapongsa T; Dombrowski M; Erez O; Than NG; Mazaki-Tovi S; Mittal P; Espinoza J; Hassan SS
    J Matern Fetal Neonatal Med; 2008 Jun; 21(6):389-402. PubMed ID: 18570117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.
    Adekola H; Romero R; Chaemsaithong P; Korzeniewski SJ; Dong Z; Yeo L; Hassan SS; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2015; 28(14):1621-32. PubMed ID: 25211383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexplained fetal death: another anti-angiogenic state.
    Espinoza J; Chaiworapongsa T; Romero R; Kim YM; Kim GJ; Nien JK; Kusanovic JP; Erez O; Bujold E; Gonçalves LF; Gomez R; Edwin S
    J Matern Fetal Neonatal Med; 2007 Jul; 20(7):495-507. PubMed ID: 17674262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble suppression of tumorigenicity-2 in pregnancy with a small-for-gestational-age fetus and with preeclampsia.
    Kanninen T; Jung E; Gallo DM; Diaz-Primera R; Romero R; Gotsch F; Suksai M; Bosco M; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2153034. PubMed ID: 36521862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute pyelonephritis during pregnancy changes the balance of angiogenic and anti-angiogenic factors in maternal plasma.
    Chaiworapongsa T; Romero R; Gotsch F; Kusanovic JP; Mittal P; Kim SK; Erez O; Vaisbuch E; Mazaki-Tovi S; Kim CJ; Dong Z; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2010 Feb; 23(2):167-78. PubMed ID: 20213923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin.
    Bujold E; Romero R; Chaiworapongsa T; Kim YM; Kim GJ; Kim MR; Espinoza J; Gonçalves LF; Edwin S; Mazor M
    J Matern Fetal Neonatal Med; 2005 Jul; 18(1):9-16. PubMed ID: 16105786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor.
    Espinoza J; Romero R; Nien JK; Gomez R; Kusanovic JP; Gonçalves LF; Medina L; Edwin S; Hassan S; Carstens M; Gonzalez R
    Am J Obstet Gynecol; 2007 Apr; 196(4):326.e1-13. PubMed ID: 17403407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
    Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
    Wathén KA; Tuutti E; Stenman UH; Alfthan H; Halmesmäki E; Finne P; Ylikorkala O; Vuorela P
    J Clin Endocrinol Metab; 2006 Jan; 91(1):180-4. PubMed ID: 16263826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products.
    Soto E; Romero R; Richani K; Espinoza J; Chaiworapongsa T; Nien JK; Edwin SS; Kim YM; Hong JS; Goncalves LF; Yeo L; Mazor M; Hassan SS; Kusanovic JP
    J Matern Fetal Neonatal Med; 2010 Jul; 23(7):646-57. PubMed ID: 19900030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice.
    Oggè G; Romero R; Kusanovic JP; Chaiworapongsa T; Dong Z; Mittal P; Vaisbuch E; Mazaki-Tovi S; Gonzalez JM; Yeo L; Hassan SS
    J Matern Fetal Neonatal Med; 2010 Aug; 23(8):820-7. PubMed ID: 20158394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award.
    Chaiworapongsa T; Romero R; Espinoza J; Bujold E; Mee Kim Y; Gonçalves LF; Gomez R; Edwin S
    Am J Obstet Gynecol; 2004 Jun; 190(6):1541-7; discussion 1547-50. PubMed ID: 15284729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).
    Chaiworapongsa T; Romero R; Erez O; Tarca AL; Conde-Agudelo A; Chaemsaithong P; Kim CJ; Kim YM; Kim JS; Yoon BH; Hassan SS; Yeo L; Korzeniewski SJ
    Am J Obstet Gynecol; 2017 Dec; 217(6):682.e1-682.e13. PubMed ID: 29037482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The profiles of soluble adhesion molecules in the "great obstetrical syndromes"
    Docheva N; Romero R; Chaemsaithong P; Tarca AL; Bhatti G; Pacora P; Panaitescu B; Chaiyasit N; Chaiworapongsa T; Maymon E; Hassan SS; Erez O
    J Matern Fetal Neonatal Med; 2019 Jul; 32(13):2113-2136. PubMed ID: 29320948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-aging factor α-klotho during human pregnancy and its expression in pregnancies complicated by small-for-gestational-age neonates and/or preeclampsia.
    Miranda J; Romero R; Korzeniewski SJ; Schwartz AG; Chaemsaithong P; Stampalija T; Yeo L; Dong Z; Hassan SS; Chrousos GP; Gold P; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2014 Mar; 27(5):449-57. PubMed ID: 23808483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.